New Complementary Diagnostic Test Available from LabCorp for Treatment of Bladder Cancer Read more about New Complementary Diagnostic Test Available from LabCorp for Treatment of Bladder Cancer
LabCorp Announces the Launch of the Epi proColon® Test for Colorectal Cancer Screening Read more about LabCorp Announces the Launch of the Epi proColon® Test for Colorectal Cancer Screening
LabCorp to Webcast Its Annual Meeting of Stockholders Read more about LabCorp to Webcast Its Annual Meeting of Stockholders
Laboratory Corporation of America® Holdings Announces 2016 First Quarter Results and Raises 2016 Guidance Read more about Laboratory Corporation of America® Holdings Announces 2016 First Quarter Results and Raises 2016 Guidance
LabCorp Hires Jonathan Zung as Group President of Clinical Development and Commercialization Services for Covance Drug Development Read more about LabCorp Hires Jonathan Zung as Group President of Clinical Development and Commercialization Services for Covance Drug Development
Conversion Right Triggered for Labcorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for Labcorp’s Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Completes Acquisition of Assets of Pathology, Inc. Read more about LabCorp Completes Acquisition of Assets of Pathology, Inc.
Covance Announces Mobile Health Solutions to Support Use of Mobile Technology in Clinical Trials Read more about Covance Announces Mobile Health Solutions to Support Use of Mobile Technology in Clinical Trials
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Read more about LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
LabCorp is Scheduled to Present at the Barclays Capital 2016 Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Barclays Capital 2016 Global Healthcare Conference
